Overview

New Medication Treatment for Stimulant Dependence

Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy of ondansetron compared with placebo in the treatment of cocaine dependence.
Phase:
Phase 2
Details
Lead Sponsor:
University of Virginia
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Central Nervous System Stimulants
Ondansetron